Overview
Changju Qu practices in Suzhou, China. Qu is rated as a Distinguished expert by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Their top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, Pancreaticoduodenectomy, and Bone Marrow Transplant.
Their clinical research consists of co-authoring 35 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 10 articles in the study of Diffuse Large B-Cell Lymphoma (DLBCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Advanced
- B-Cell LymphomaQu isAdvanced. Learn about B-Cell Lymphoma.
- Non-Hodgkin Lymphoma
- Experienced
- Acute Myeloid Leukemia (AML)
- Bone Marrow TransplantQu isExperienced. Learn about Bone Marrow Transplant.
- GallstonesQu isExperienced. Learn about Gallstones.
- LeukemiaQu isExperienced. Learn about Leukemia.
- Mycoplasma PneumoniaQu isExperienced. Learn about Mycoplasma Pneumonia.
- Neurotoxicity SyndromesQu isExperienced. Learn about Neurotoxicity Syndromes.